2025 Federal Vaccine Policy Changes Impact Insurance Coverage Mandates
Find out how 2025 federal vaccine policy changes by the CDC and HHS affect health insurance coverage requirements and industry compliance.
US Health Providers Reject ACIP’s New Hepatitis B Vaccination Guidance
US health providers and state health departments reject ACIP's updated hepatitis B vaccine guidelines, continuing universal newborn vaccination amid regulatory debate and insurance coverage assurance.
Safe Food Coalition Calls for Urgent Infant Formula Safety Oversight After Botulism Outbreak
The Safe Food Coalition urges urgent regulatory action after a Clostridium botulinum outbreak linked to ByHeart infant formula reveals inspection gaps, stressing need for enhanced safety protocols in infant nutrition products.
NYC HIV Rates Rise Amid Federal Funding Cuts to Prevention Programs
New York City reports a 5.4% rise in HIV cases in 2024 amid proposed federal cuts exceeding $41 million to local HIV prevention and treatment funding, highlighting ongoing health disparities and socioeconomic challenges.
CDC Proposes New Hepatitis B Vaccine Guidance: Insurance Coverage Unchanged
CDC advisory panel updates hepatitis B vaccine guidelines recommending shared clinical decision-making for newborns, while insurance coverage remains intact under ACA and Medicaid mandates.
New Jersey Maintains Newborn Hepatitis B Vaccination Despite Federal Panel Shift
New Jersey will continue recommending hepatitis B vaccination at birth for newborns, diverging from new federal panel advice suggesting delayed dosing. The state prioritizes early protection to reduce hepatitis B transmission and maintain insurance coverage standards.
ACIP Revises Newborn Hepatitis B Vaccine Guidelines Amid Safety and Consent Concerns
The ACIP has revised its hepatitis B vaccination guidelines for newborns, shifting from universal birth dosing to selective administration based on maternal infection status, citing safety and parental consent concerns. This impacts CDC policy and health insurance coverage across the U.S.
ACIP Revises Hepatitis B Vaccination Guidelines, Affecting US Immunization Policies
The Advisory Committee on Immunization Practices updates hepatitis B vaccination guidelines, recommending selective birth doses and serologic testing, impacting US immunization policies and insurance coverage.
CDC Panel Narrows Hepatitis B Vaccine Recommendation for Newborns
CDC's vaccine advisory panel recommends limiting hepatitis B immunization at birth to infants born to hepatitis B positive or unknown status mothers, revising a 30+ year-old universal policy. The decision reflects shifting vaccine guidance and ongoing debates on vaccine safety and dosing.
CDC ACIP Recommends Individual Decision-Making for Hepatitis B Birth Dose in Low-Risk Infants
CDC's ACIP endorses individual-based decision-making for hepatitis B birth dose vaccination in infants of hepatitis B-negative mothers, aligning with updated immunization schedules and insurance coverage policies.